Definitions
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun A
monoclonal antibody against nerve growth factor, used as a treatment for pain.
Etymologies
from Wiktionary, Creative Commons Attribution/Share-Alike License
Support
Help support Wordnik (and make this page ad-free) by adopting the word tanezumab.
Examples
-
Pfizer announced earlier this year that tanezumab, which is further along in the same class, was also put on hold.
Painful Clinical Hold? Not Really. (ABT, JNJ, PFE, REGN, SNY) 2010
-
Pfizer announced earlier this year that tanezumab, which is further along in the same class, was also put on hold.
Painful Clinical Hold? Not Really. (ABT, JNJ, PFE, REGN, SNY) 2010
-
Pfizer Inc. said in June that it would suspend osteoarthritis trials of its drug tanezumab after a small number of patients reported worsening symptoms that required joint replacement.
Regeneron's Pain Drug Put on Hold by FDA Katherine Hobson 2010
-
Pfizer has terminated at least two clinical trials of tanezumab because so much already has passed since the suspensions.
J Dinah Wisenberg Brin 2010
-
It later suspended trials of tanezumab for chronic low-back pain and diabetes-related nerve pain, but said it would keep studying it for some other conditions.
Regeneron's Pain Drug Put on Hold by FDA Katherine Hobson 2010
-
Pfizer Inc. said it would suspend osteoarthritis trials of its pain drug tanezumab after a "small number" of reports that patients 'ailments worsened to the point of needing joint replacement.
-
AstraZeneca's U.S. biologics unit, MedImmune, said it had voluntarily halted early-stage trials of medi-578 in July, without regulatory request, shortly after Pfizer Inc. suspended certain trials of its tanezumab drug over joint concerns.
J Dinah Wisenberg Brin 2010
-
Pfizer lost 42 cents, or 2.8%, to 14.46, after saying it would suspend osteoarthritis trials of its pain drug tanezumab after a "small number" of reports that patients 'ailments worsened to the point of needing joint replacement.
-
The company "will continue to work with the FDA to reach a common understanding about the appropriate scope for continued clinical investigation of tanezumab," he said.
Regeneron's Pain Drug Put on Hold by FDA Katherine Hobson 2010
-
To date, Pfizer said the adverse event has not been observed in patients without osteoarthritis that are taking tanezumab.
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.